QT Vascular in US$13.14m convertible debt investment to fund growth
Published Fri, Jul 24, 2015 · 10:53 AM
QT Vascular, a developer of minimally invasive products for the treatment of vascular diseases, has entered into a US$13.14 million convertible debt investment to fund its next growth phase.
This comes less than a month after the company entered into a US$12 million convertible bond investment to further develop its Drug-Coated Chocolate platform.
On Friday, the counter closed down 0.84 per cent, or 0.1 Singapore cent, at S$0.118.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Oil settles higher on supply concerns in the Mid-East, economic woes subdue gains
S-Reits falter as investors weigh possibility of zero rate cuts in 2024
CapitaLand Investment posts total revenue of S$650 million for Q1
Europe: Stoxx 600 logs best day in three months as banks shine
US: Stocks rally after strong tech results
Porsche posts Q1 profit drop on ramp-up costs